TMBR Skyrocketed

TMBR (TMBR:NYSEMKT) rocketted at $1.53, a gain of 23.4%. On Tue, Apr 20, 2021, TMBR:NYSEMKT hit a New 2-Week Low of $1.24. The stock got featured on our News Catalysts scanner on Fri, Apr 02, 2021 at 06:54 PM in the 'INVESTOR UPDATE' category. From Tue, Apr 06, 2021, the stock recorded 20.00% Up Days and 45.45% Green Days

The stock spiked on Thu, Apr 01, 2021 at $2.39 with a volume of 5M+.

About TMBR (TMBR:NYSEMKT)

Timber Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of treatments for orphan dermatologic diseases. The company's investigational therapies have proven mechanisms-of-action backed by decades of clinical experience and well-established CMC (chemistry, manufacturing and control) and safety profiles. It is initially focused on developing non-systemic treatments for rare dermatologic diseases including congenital ichthyosis (CI), tuberous sclerosis complex (TSC), and localized scleroderma. Its development pipeline includes TMB-001 (Topical Isotretinoin), TMB-002 (Topical Rapamycin), and TMB-003 (Topical / Subcutaneous ET-A Receptor Antagonist).